GPBAR1 and colitis: Biagioli et al. reported that TGR5−/− mice presented enhanced M1 recruitment and intestinal inflammation, whereas TGR5 agonist BAR501 promoted the macrophages shifting from M1 to M2 phenotype and brought about reduced pro-inflammatory cytokines and relieved experimental colitis.